LeonaBio (LONA) Other Gross PP&E Adjustments (2019 - 2026)
LeonaBio (LONA) reported Other Gross PP&E Adjustments of $5.3 million for Q1 2026, up 5.64% year-over-year from $5.0 million in Q1 2025, and up 80.94% on a QoQ basis from $2.9 million in Q4 2025.
LeonaBio (LONA) has 8 years of Other Gross PP&E Adjustments data on file, last reported at $5.3 million in Q1 2026.
- Quarterly Other Gross PP&E Adjustments rose 5.64% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (up 5.64% YoY) and the FY2025 annual result came in at $2.9 million, up 41.33% from the prior year.
- Other Gross PP&E Adjustments climbed to $5.3 million in Q1 2026 per LONA's latest filing, from $2.9 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $5.3 million in Q1 2026 and bottomed at $2.1 million in Q4 2024.
- The 5-year median for Other Gross PP&E Adjustments is $4.5 million (2023), against an average of $4.1 million.
- The widest annual swing landed in 2022, when Other Gross PP&E Adjustments surged 118.49%; it then declined 15.03% in 2023.
- Tracing LONA's Other Gross PP&E Adjustments over 5 years: stood at $2.5 million in 2022, then declined by 15.03% to $2.1 million in 2023, then declined by 2.13% to $2.1 million in 2024, then soared by 41.33% to $2.9 million in 2025, then jumped by 80.94% to $5.3 million in 2026.
- Per Business Quant, the three latest LONA Other Gross PP&E Adjustments figures stand at $5.3 million (Q1 2026), $2.9 million (Q4 2025), and $5.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -189.30 Mn |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | 5.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.28 Mn |
| Mar 31, 2026 | 5.28 Mn |
| Dec 31, 2025 | 2.92 Mn |
| Dec 31, 2025 | 2.92 Mn |
| Sep 30, 2025 | 5.13 Mn |
| Sep 30, 2025 | 5.13 Mn |
| Jun 30, 2025 | 5.06 Mn |
| Jun 30, 2025 | 5.06 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 2.06 Mn |
| Dec 31, 2024 | 2.06 Mn |
| Sep 30, 2024 | 4.87 Mn |
| Sep 30, 2024 | 4.87 Mn |
| Jun 30, 2024 | 4.81 Mn |
| Jun 30, 2024 | 4.81 Mn |
| Mar 31, 2024 | 4.72 Mn |
| Mar 31, 2024 | 4.72 Mn |
| Dec 31, 2023 | 2.11 Mn |
| Dec 31, 2023 | 2.11 Mn |
| Sep 30, 2023 | 4.62 Mn |
| Sep 30, 2023 | 4.62 Mn |
| Jun 30, 2023 | 4.54 Mn |
| Jun 30, 2023 | 4.54 Mn |
| Mar 31, 2023 | 4.45 Mn |
| Mar 31, 2023 | 4.45 Mn |
| Dec 31, 2022 | 2.48 Mn |
| Dec 31, 2022 | 2.48 Mn |
| Sep 30, 2022 | 3.83 Mn |
| Sep 30, 2022 | 3.83 Mn |
| Jun 30, 2022 | 3.54 Mn |
| Jun 30, 2022 | 3.54 Mn |
| Mar 31, 2022 | 3.62 Mn |
| Mar 31, 2022 | 3.62 Mn |
| Dec 31, 2021 | 2.02 Mn |
| Dec 31, 2021 | 2.02 Mn |
| Sep 30, 2021 | 1.95 Mn |
| Sep 30, 2021 | 1.95 Mn |
| Jun 30, 2021 | 1.67 Mn |
| Jun 30, 2021 | 1.67 Mn |
| Mar 31, 2021 | 1.66 Mn |
| Mar 31, 2021 | 1.66 Mn |
| Dec 31, 2020 | 1.68 Mn |
| Dec 31, 2020 | 1.68 Mn |
| Sep 30, 2020 | -959,000.00 |
| Sep 30, 2020 | -959,000.00 |
| Dec 31, 2019 | -13,000.00 |
| Dec 31, 2019 | -13,000.00 |